share_log

西藏药业(600211.SH)发布前三季度业绩,净利润7.92亿元,同比下降7.42%

tibet rhodiola pharmaceutical holding (600211.SH) released its performance for the first three quarters, with a net income of 0.792 billion yuan, a 7.42% year-on-year decrease.

Zhitong Finance ·  Oct 29 15:59

Tibet Rhodiola Pharmaceutical Holding (600211.SH) released the third quarter report for 2024, with the company's revenue for the first three quarters of the year reaching...

According to the Zhitong Finance APP, Tibet Rhodiola Pharmaceutical Holding (600211.SH) has released the third quarter report for 2024. The company's revenue for the first three quarters decreased by 8.13% to 2.175 billion yuan; the net income attributable to shareholders of the listed company decreased by 7.42% to 0.792 billion yuan; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses decreased by 6.22% to 0.687 billion yuan; and the basic earnings per share were 2.46 yuan per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment